NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.

about

NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.

Item

http://www.wikidata.org/entity/Q51050262

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

NFκBP65 transcription factor m ...... transporters in breast cancer.

@en

NFκBP65 transcription factor m ...... transporters in breast cancer.

@nl

type

Item

label

NFκBP65 transcription factor m ...... transporters in breast cancer.

@en

NFκBP65 transcription factor m ...... transporters in breast cancer.

@nl

prefLabel

NFκBP65 transcription factor m ...... transporters in breast cancer.

@en

NFκBP65 transcription factor m ...... transporters in breast cancer.

@nl

P1476

NFκBP65 transcription factor m ...... transporters in breast cancer.

@en

P2093

Balal Barazvan

http://www.w3.org/2001/XMLSchema#string

Jafar Soleimani Rad

http://www.w3.org/2001/XMLSchema#string

Kobra Velaei

http://www.w3.org/2001/XMLSchema#string

Sina Soltani

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Targeting the Bcl-2 family for cancer therapy

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

NF-kappa B genes have a major role in inflammatory breast cancer

The noncanonical NF-κB pathway.

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.

Small-molecule Bax agonists for cancer therapy.

Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.

Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.

P2888

s12282-016-0738-8

P304

552-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12282-016-0738-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nasser Samadi

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27878697

http://www.w3.org/2001/XMLSchema#string